Welcome to See King Alpha's Wall Street breakfast, where we cover the top news for investors every morning.

Good morning. Today is Monday, December 18th. I'm Julie Morgan.

Illumina plans to divest Grail.

IBM is making a $2 billion purchase, and a beloved rodent is reportedly up for sale. Illumina plans to divest cancer test developer Grail after an appeals court ruling on Friday.

The Fifth Circuit Court of Appeals ruled that the FTC was correct in finding the deal anti-competitive,

though the court vacated the regulator's order and remanded the case for reconsideration at the

FTC.

Illumina has decided not to appeal the court's ruling after reviewing it.

According to a statement on Sunday, the company will divest Grail, either through a sale

or a capital market's, with the goal of finalizing the terms by the end of Q2.

The FTC originally ordered Illumina to divest grail in April, and the European Commission issued that same order in October.

End point news reported late last month that Illumina has been contacted by parties,

interested in buying or investing in Grail which it acquired for

around seven billion dollars in 2021. IBM Monday today said it has entered

into a definitive agreement with Software A.G.

Majority owned by Silver Lake to purchase stream sets and web methods.

The transaction is for the euro equivalent of 2.184 billion dollars in cash.

The pending acquisition follows a more than 20 year relationship between IBM and software AG.

The deal is expected to be completed in the second. between IBM and Software AG.

The deal is expected to be completed in the second quarter of 2024.

Chuck E. Cheese, the beloved restaurant chain that made a comeback after its bankruptcy three years ago is exploring a

potential sale. According to a Reuters report citing people familiar with the

...